Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Goat Anti Human IgG (H+L) (AP-Linked)

Product Specifications

CAS Number

9007-83-4

Gene Name

[IgG]

Reactivity

Human

Storage Conditions

Keep the product at 2-8 °C with sterile condition in the dark. For long term storage, add an equal amount of glycerol, mix and stored at -20 °C. Alternatively, the product may be aliquoted and stored at -70 °C or below without adding glycerol. Avoid freezing and thawing frequently.

Specificity

The affinity purified antibody is labeled by Alkaline Phosphatase (AP). This antibody was raised in goat by immunizing purified human IgG. These antisera were then immunoaffinity purified from the antigen specific column with minimum cross-reaction to bovine, mouse, and rabbit serum proteins. No antibody was detected against non-immunoglobulin serum proteins.

Short Name

[IgG]

Other Product Names

[IgG]

NCBI GI Number

185362

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

SCAMP1 AAV Vector (Human) (CMV)
43084101 1 µg

SCAMP1 AAV Vector (Human) (CMV)

Ask
View Details
LRP5 antibody
FNab04848 100 µg

LRP5 antibody

Ask
View Details
RASD1 (Activator of G-protein Signaling 1, AGS1, Dexamethasone-induced Ras-related Protein 1, DEXRAS1, MGC:26290) (AP) discontinued
132336-AP 100 µL

RASD1 (Activator of G-protein Signaling 1, AGS1, Dexamethasone-induced Ras-related Protein 1, DEXRAS1, MGC:26290) (AP) discontinued

Ask
View Details
SLC22A7 (Solute Carrier Family 22 Member 7, Solute Carrier Family 22 (Organic Anion Transporter), Member 7)
491924 100 µL

SLC22A7 (Solute Carrier Family 22 Member 7, Solute Carrier Family 22 (Organic Anion Transporter), Member 7)

Ask
View Details
V9 Anti-Human Claudin 18.2 (Zolbetuximab)
BP535601-01 1 mg

V9 Anti-Human Claudin 18.2 (Zolbetuximab)

Ask
View Details
V9 Anti-Human Claudin 18.2 (Zolbetuximab)
BP535601-02 5 mg

V9 Anti-Human Claudin 18.2 (Zolbetuximab)

Ask
View Details